Clincosm LogoSign in Get a demo

Blood Collection for COM/BSBS

Sponsor
University of Central Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT06082661
Collaborator
(none)
5,000
Enrollment
1
Location
59.3
Anticipated Duration (Months)
84.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The objective of this biospecimen collection protocol is the acquisition of blood from adult volunteers. These biospecimens will be transferred to the College of Medicine (COM)/Burnett School of Biomedical Sciences (BSBS) research scientists and their research teams for testing according to their separate IRB-approved/exempted protocols. These separate IRBapproved protocols cannot be for genetic testing.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human blood (or its derivatives) for testing of assays and devices.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Blood Collection for Use With Translational, Biomedical Research at UCF College of Medicine and Burnett School of Biomedical Sciences
    Actual Study Start Date :
    Jun 23, 2022
    Anticipated Primary Completion Date :
    Jun 1, 2027
    Anticipated Study Completion Date :
    Jun 1, 2027

    Outcome Measures

    Primary Outcome Measures

    1. Acquisition of blood samples for testing [5 years]

      This is a non-clinical, biospecimen collection study.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Male or female adults

    • 18 years old or older

    • weigh over 110 pounds

    • able to provide informed consent

    Exclusion Criteria:

    • pregnant/suspect to be pregnant

    • prisoners

    • have donated blood anywhere in the preceding 16 weeks

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Central Florida Orlando Florida United States 32816

    Sponsors and Collaborators

    • University of Central Florida

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Central Florida
    ClinicalTrials.gov Identifier:
    NCT06082661
    Other Study ID Numbers:
    • STUDY00003409
    First Posted:
    Oct 13, 2023
    Last Update Posted:
    Oct 13, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Central Florida
    Blood
    Healthy

    Study Results

    No Results Posted as of Oct 13, 2023